Mirum Pharmaceuticals Inc
MIRMHealthcare|Biotechnology|USA
$122.13
-5.67 (-4.44%)
About
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Stock Price
+130.4%(1Y)
Pipeline Summary
40 total trials3
Phase 1
20
Phase 2
12
Phase 3
1
Phase 4
Active: 5Terminated: 2Completed: 21Recruiting: 7APPROVED_FOR_MARKETING: 1NOT_YET_RECRUITING: 1Withdrawn: 2ENROLLING_BY_INVITATION: 1
Active Trials (12)
The REPLACE Registry for Cholbam® (Cholic Acid)
NCT03115086Bile Acid Synthesis Disorders
Active
Enrollment: 55 participants
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
NCT07454837Chronic Hepatitis D
Phase 2Phase 3Recruiting
Enrollment: 120 participants
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
NCT06553768Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
Phase 3Active
Enrollment: 90 participants
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
NCT04663308Primary Sclerosing Cholangitis
Phase 2Active
Enrollment: 182 participants
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
NCT05050136Primary Biliary Cholangitis
Phase 2Recruiting
Enrollment: 260 participants
BioScore
5.8/10
Watchlist
Ownership
Recent Insider Trades
Peetz ChristopherSELL
2026-07-0620,000 shares @ $122.27
BJERKHOLT ERICSELL
2026-07-065,000 shares @ $122.25
Howe JolandaSELL
2026-07-012,721 shares @ $120
Howe JolandaSELL
2026-06-172,594 shares @ $101.95
BJERKHOLT ERICSELL
2026-06-085,000 shares @ $93.82
Recent News
2026-07-09 00:03:06
2026-07-07 17:01:01
2026-07-03 00:03:01
2026-07-02 15:25:50
2026-06-19 00:02:47
Data last updated: Jul 12, 2026, 07:37 PM